194 related articles for article (PubMed ID: 25757200)
21. Increased 18F-FDG uptake in degenerative disease of the spine: Characterization with 18F-FDG PET/CT.
Rosen RS; Fayad L; Wahl RL
J Nucl Med; 2006 Aug; 47(8):1274-80. PubMed ID: 16883005
[TBL] [Abstract][Full Text] [Related]
22. In newly diagnosed diffuse large B-cell lymphoma, determination of bone marrow involvement with 18F-FDG PET/CT provides better diagnostic performance and prognostic stratification than does biopsy.
Berthet L; Cochet A; Kanoun S; Berriolo-Riedinger A; Humbert O; Toubeau M; Dygai-Cochet I; Legouge C; Casasnovas O; Brunotte F
J Nucl Med; 2013 Aug; 54(8):1244-50. PubMed ID: 23674577
[TBL] [Abstract][Full Text] [Related]
23. 18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas.
Noda Y; Kanematsu M; Goshima S; Suzui N; Hirose Y; Matsunaga K; Nishibori H; Kondo H; Watanabe H; Kawada H; Kawai N; Tanahashi Y; Bae KT
Eur Radiol; 2015 Oct; 25(10):3009-16. PubMed ID: 25854217
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of 18F-FDG uptake and arterial wall calcifications using 18F-FDG PET/CT.
Ben-Haim S; Kupzov E; Tamir A; Israel O
J Nucl Med; 2004 Nov; 45(11):1816-21. PubMed ID: 15534049
[TBL] [Abstract][Full Text] [Related]
25. Correcting tumour SUV for enhanced bone marrow uptake: retrospective 18F-FDG PET/CT studies.
Teo BK; Badiee S; Hadi M; Lam T; Johnson L; Seo Y; Bacharach SL; Hasegawa BH; Franc BL
Nucl Med Commun; 2008 Apr; 29(4):359-66. PubMed ID: 18317301
[TBL] [Abstract][Full Text] [Related]
26. Uptake in supraclavicular area fat ("USA-Fat"): description on 18F-FDG PET/CT.
Cohade C; Osman M; Pannu HK; Wahl RL
J Nucl Med; 2003 Feb; 44(2):170-6. PubMed ID: 12571205
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for N2 metastasis in patients with non-small-cell lung cancer: multivariate analyses of 18F-FDG PET/CT data.
Su M; Li Y; Li F; Li L; Tian R
Nucl Med Commun; 2014 Sep; 35(9):916-21. PubMed ID: 24785010
[TBL] [Abstract][Full Text] [Related]
28. 18F-FDG PET CT as a prognostic factor in hepatocellular carcinoma.
Cho E; Jun CH; Kim BS; Son DJ; Choi WS; Choi SK
Turk J Gastroenterol; 2015 Jul; 26(4):344-50. PubMed ID: 26039005
[TBL] [Abstract][Full Text] [Related]
29. Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.
Hashimoto Y; Tsujikawa T; Kondo C; Maki M; Momose M; Nagai A; Ohnuki T; Nishikawa T; Kusakabe K
J Nucl Med; 2006 Mar; 47(3):426-31. PubMed ID: 16513611
[TBL] [Abstract][Full Text] [Related]
30. Repeated positron emission tomography-computed tomography and perfusion-computed tomography imaging in rectal cancer: fluorodeoxyglucose uptake corresponds with tumor perfusion.
Janssen MH; Aerts HJ; Buijsen J; Lambin P; Lammering G; Öllers MC
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):849-55. PubMed ID: 21392896
[TBL] [Abstract][Full Text] [Related]
31. Correlation of the apparent diffusion coefficient (ADC) with the standardized uptake value (SUV) in hybrid 18F-FDG PET/MRI in non-small cell lung cancer (NSCLC) lesions: initial results.
Heusch P; Buchbender C; Köhler J; Nensa F; Beiderwellen K; Kühl H; Lanzman RS; Wittsack HJ; Gomez B; Gauler T; Schuler M; Forsting M; Bockisch A; Antoch G; Heusner TA
Rofo; 2013 Nov; 185(11):1056-62. PubMed ID: 23860802
[TBL] [Abstract][Full Text] [Related]
32. Higher reliability of 18F-FDG target background ratio compared to standardized uptake value in vulnerable carotid plaque detection: a pilot study.
Niccoli Asabella A; Ciccone MM; Cortese F; Scicchitano P; Gesualdo M; Zito A; Di Palo A; Angiletta D; Regina G; Marzullo A; Rubini G
Ann Nucl Med; 2014 Jul; 28(6):571-9. PubMed ID: 24737136
[TBL] [Abstract][Full Text] [Related]
33. The predictive value of metabolic tumor volume on FDG PET/CT for transarterial chemoembolization and transarterial chemotherapy infusion in hepatocellular carcinoma patients without extrahepatic metastasis.
Lee JW; Yun M; Cho A; Han KH; Kim DY; Lee SM; Lee JD
Ann Nucl Med; 2015 Jun; 29(5):400-8. PubMed ID: 25652647
[TBL] [Abstract][Full Text] [Related]
34. [(18)F]FDG-PET standard uptake value as a metabolic predictor of bone marrow response to radiation: impact on acute and late hematological toxicity in cervical cancer patients treated with chemoradiation therapy.
Elicin O; Callaway S; Prior JO; Bourhis J; Ozsahin M; Herrera FG
Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1099-107. PubMed ID: 25442041
[TBL] [Abstract][Full Text] [Related]
35. Utility of 18F-FDG PET/CT in the diagnosis and staging of extramammary Paget's disease.
Tian Y; Wu HB; Li DL; Li HS; Zhou WL; Wang QS
Nucl Med Commun; 2015 Sep; 36(9):892-7. PubMed ID: 25932540
[TBL] [Abstract][Full Text] [Related]
36. Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma.
Imsande HM; Davison JM; Truong MT; Devaiah AK; Mercier GA; Ozonoff AJ; Subramaniam RM
AJR Am J Roentgenol; 2011 Oct; 197(4):976-80. PubMed ID: 21940588
[TBL] [Abstract][Full Text] [Related]
37. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
38. 18F-FDG PET/CT makes a significant contribution to diagnosis of malignancy in patients with cervical lymphadenopathy: a study using optimal scale regression tests.
Ouyang L; Shi ZY; Lin ZG
Chin Med J (Engl); 2013 Feb; 126(4):659-67. PubMed ID: 23422185
[TBL] [Abstract][Full Text] [Related]
39. Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw.
Fleisher KE; Raad RA; Rakheja R; Gupta V; Chan KC; Friedman KP; Mourtzikos KA; Janal M; Glickman RS
J Oral Maxillofac Surg; 2014 Oct; 72(10):1957-65. PubMed ID: 25053572
[TBL] [Abstract][Full Text] [Related]
40. Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
Huang YE; Chen CF; Huang YJ; Konda SD; Appelbaum DE; Pu Y
Acta Radiol; 2010 Sep; 51(7):782-8. PubMed ID: 20707663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]